Login
Join
FOLLOW:
Subscribe Free
Magazine
eNewsletter
Checkout
Menu
Magazine
News
Opinions
Top 30
Research
Supply Chain
Device Sectors
Directory
Events
Resources
Microsites
More
Magazine
News
Opinions
Top 30
Research
Supply Chain
Device Sectors
Directory
Events
Resources
Microsites
Current / Back Issues
Features
Editorial
Digital Edition
eNewsletter Archive
Our Team
Editorial Guidelines
Reprints
Subscribe Now
Advertise Now
Top Features
Partner Preference in Full-Service Medical Device Outsourcing
Spot Check: A Discussion of the In-Vitro Diagnostics Market
Innovative Iteration for Medical Device Design
Medical Tubing & Extrusion Experts Offer Perspectives on Industry
Supplying Sustainable Surfaces for Medical Device Coating and Finishing
OEM News
Supplier News
Service / Press Releases
Online Exclusives
Press Releases
People in the News
Product & Service Releases
Supplier News
Medtech Makers
Technical Features
International News
Videos
Product & Service Releases
Live From Shows
Regulatory
Financial/Business
Top News
ConKay Medical Systems Raises $1.8 Million in Seed Funding
Owlet's Dream Sock OTC Infant Pulse Oximeter OK'ed in Europe
HeartBeam Begins Study of its AIMIGo System
Baxter Reports Q1 Results; Raises Full-Year Guidance
Brent Lang Named to Outset Medical's Board of Directors
From the Editor
Blogs
Guest Opinions
Top Opinions
Partner Preference in Full-Service Medical Device Outsourcing
Spot Check: A Discussion of the In-Vitro Diagnostics Market
Innovative Iteration for Medical Device Design
Medical Tubing & Extrusion Experts Offer Perspectives on Industry
Supplying Sustainable Surfaces for Medical Device Coating and Finishing
Top 30 Medical Device Companies
Market Data
White Papers
Top Research
Musk Shares More Than a Tweet About Brain Implant Tech
Process and Design Looping: Medtech's Total Product Lifecycle
13 Best Practices for Productive Engagement with Biomedical Textile Partners
Culture and Talent Experience: Keys to Organizational Performance
Is It Worth Following Trends in Medtech?
3D/Additive Manufacturing
Contract Manufacturing
Electronics
Machining & Laser Processing
Materials
Molding
Packaging & Sterilization
R&D & Design
Software & IT
Testing
Tubing & Extrusion
Cardiovascular
Diagnostics
Digital Health
Neurological
Patient Monitoring
Surgical
Orthopedics
All Companies
Categories
Company Capabilities
Add New Company
Outsourcing Directory
Braxton Manufacturing
Providence Enterprise USA Inc.
Poly-Med, Inc.
Cirtec Medical
Qosina Corp.
MPO Summit
Industry Events
Webinars
Live From Show Event
Industry Associations
Videos
Career Central
eBook
Slideshows
Top Resources
The Frightening Earlier Days of Wireless Medtech—#ThrowbackThursday
Plastic Welding Innovation Seals Novel Endodontic Cannula
Overcoming Coagulation-Drug Specific Diagnostic Challenges
Introducing Voice Recognition Tech (and Building an Internet Library)—#ThrowbackThursday
Does China’s Leading Place in the Global Medtech Market Reflect the Commercial Reality?
Companies
News Releases
Product Releases
Press Releases
Product Spec Sheets
Service Releases
Case Studies
White Papers
Brochures
Videos
Outsourcing Directory
Braxton Manufacturing
Providence Enterprise USA Inc.
Poly-Med, Inc.
Cirtec Medical
Qosina Corp.
Magazine
Current/Back Issues
Features
Editorial
Columns
Digital Editions
Subscribe Now
Advertise Now
News
Directory
All Companies
ALL CATEGORIES
Industry Associations
Company Capabilities
Add Your Company
Supply Chain
3D/Additive Manufacturing
Contract Manufacturing
Electronics
Machining & Laser Processing
Materials
Molding
Packaging & Sterilization
R&D & Design
Software & IT
Testing
Tubing & Extrusion
Device Sectors
Cardiovascular
Diagnostics
Digital Health
Neurological
Patient Monitoring
Surgical
Orthopedics
Top 30 Company Report
Expert Insights
Slideshows
Videos
eBook
Resources
Podcasts
Infographics
Whitepapers
Research
White Papers
Case Studies
Product Spec Sheets
Market Data
MPO Summit
Events
Industry Events
Live From Show Events
Webinars
Microsite
Companies
Product Releases
Product Spec Sheets
Services
White Papers / Tech Papers
Press Releases
Videos
Literature / Brochures
Case Studies
About Us
About Us
Contact Us
Advertise with Us
eNewsletter Archive
Privacy Policy
Terms of Use
Search Results for '
livanova
'
Search For:
Refine by Dates:
From:
To:
Past 7 Days
|
Past 30 Days
Refine By Content:
All
Blog
Breaking News
Business Process
Buyers Guide Companies
Career Central
Case Studies
Columns
Content Microsite
Datawatch Column
Ebook
Editorial
Employer Profile
Expert's Opinion
Features
Glossary
Industry Articles
Industry Events
Industry News
Infographics
International News
Jobs
Literature / Brochures
Live From Shows
Market Data
News Releases
Online Exclusives
People In The News
Photo Gallery
Podcasts
Press Releases
Product And Service Releases
Product Releases
Product Spec Sheets
Product Spotlight
Regulatory News
Salary Survey
Services
Slideshows
Sponsored Content
Technical Features
Top30
Videos
Webinars
White Papers / Tech Papers
LivaNova Taps J&J MedTech Exec as Chief Innovation Officer
Ahmet Tezel, Ph.D. was most recently Company Group Chairman at J&J MedTech and led its global R&D and innovation teams.
Sam Brusco, Associate Editor
04.30.24
LivaNova Issues Update on Previous Cybersecurity Incident
LivaNova learned on April 10 that unauthorized parties obtained identifiable personal info of U.S. patients in a 2023 cybersecurity incident.
Sam Brusco, Associate Editor
04.26.24
Neurological
LivaNova Expects Positive Outcome of OSPREY Sleep Apnea Trial
The company said there’s an over 97.5% probability the OSPREY trial will meet its primary endpoint.
Sam Brusco, Associate Editor
03.21.24
LivaNova Hires J&J MedTech Exec Vladimir Makatsaria as CEO
Makatsaria will take office on March 1, succeeding interim CEO and board chair Bill Kozy.
Sam Brusco, Associate Editor
02.05.24
Cardiovascular
LivaNova Winds Down Advanced Circulatory Support Business Unit
Aims to increase strategic focus on its core Cardiopulmonary and Neuromodulation business units.
Charles Sternberg, Associate Editor
01.08.24
Software & IT
LivaNova Discloses Cybersecurity Incident, Reports Disrupted IT Systems
The company admitted it couldn’t determine, at this time, the extent of the cybersecurity event’s impact.
Sam Brusco, Associate Editor
11.21.23
LivaNova Elects Former NuVasive CEO J. Christopher Barry to Board
Before leading NuVasive, Barry also had a long career at Medtronic and Covidien.
Sam Brusco, Associate Editor
10.06.23
Cardiovascular
|
Patient Monitoring
LivaNova Unveils Essenz In-Line Blood Monitor
The FDA-cleared, CE marked Essenz ILBM measures essential blood parameters during cardiopulmonary bypass procedures.
Sam Brusco, Associate Editor
08.30.23
LivaNova CEO Damien McDonald Resigns
No reason was given for resignation; board chair William Kozy became interim CEO effective immediately.
Sam Brusco, Associate Editor
04.17.23
Cardiovascular
LivaNova Begins Limited European Release of the Essenz Perfusion System
Catharina Hospital (The Netherlands) was the first hospital worldwide to carry out clinical cases with the Essenz Perfusion System.
Michael Barbella, Managing Editor
04.05.23
Cardiovascular
LivaNova's Essenz Heart-Lung Machine Earns FDA Nod
The new heart-lung machine supports cardiopulmonary bypass procedures.
Sam Brusco, Associate Editor
03.10.23
Neurological
LivaNova Releases SenTiva DUO VNS for Drug-Resistant Epilepsy
New dual-pin header differs from the original SenTiva.
Sam Brusco, Associate Editor
02.03.23
Cardiovascular
LivaNova's LifeSPARC Earns FDA Nod for ECMO
Platform simplifies life support, making life-saving technology more accessible to hospitals and critically ill patients.
Sam Brusco, Associate Editor
11.18.22
Cardiovascular
LivaNova's Recall of the LifeSPARC System Is Class I
Due to a software error, there's a risk of unintentional extended pump stop during controller Critical Failure.
Sam Brusco, Associate Editor
09.30.22
LivaNova Marks First Patient Implant in its Sleep Apnea Study
OSPREY clinical trial to evaluate effectiveness of hypoglossal nerve stimulation in treating obstructive sleep apnea.
Michael Barbella, Managing Editor
04.22.22
Patient Monitoring
LivaNova Receives FDA Clearance and CE Mark for Essenz Patient Monitor
Initiates targeted commercial launch of the monitor for cardiopulmonary bypass procedures.
Charles Sternberg, Associate Editor
04.11.22
Neurological
FDA Approves LivaNova's aura6000 Sleep Apnea Study
aura6000 to treat adult patients with moderate to severe obstructive sleep apnea.
Business Wire
06.16.21
Neurological
LivaNova, Verily Begin Difficult-to-Treat Depression Study
Verily research tools will evaluate real-world VNS Therapy effectiveness as adjunctive difficult-to-treat depression treatment.
Sam Brusco, Associate Editor
04.27.21
Patient Monitoring
FDA Grants 510(k) Clearance to LivaNova’s B-Capta
An in-line, blood-gas monitoring system integrated into the S5 Heart-Lung Machine.
Charles Sternberg, Assistant Editor
04.20.21
LivaNova Announces Board Changes
Update includes the appointment of a new member as well as board leadership changes.
Business Wire
12.07.20
Cardiovascular
LivaNova to Sell Heart Valve Biz to Gyrus Capital for $73M
Enables company to sharpen its focus within primary platforms, neuromodulation and cardiovascular.
Business Wire
12.03.20
LivaNova Launches Perceval Plus Aortic Heart Valve in Europe
The next-generation sutureless surgical technology is based on a clinically proven platform and designed for valve durability.
Business Wire
09.16.20
LivaNova Bi-Flow Cannula Receives CE Mark for ECMO Applications
Bi-Flow is first bidirectional femoral arterial cannula validated for 29 days’ use.
Business Wire
06.24.20
Neurological
LivaNova's Symmetry VNS Therapy Gains CE Mark for Difficult-to-Treat Depression
Symmetry sends mild electric pulses to the vagus nerve, which is connected to areas of the brain that control mood.
Business Wire
03.09.20
Cardiovascular
|
Surgical
FDA OKs LivaNova's 3T Heater-Cooler Device Modification
Modification includes installation of 3T Aerosol Collection Set, testing that demonstrates effectiveness of operating instructions.
Business Wire
02.26.20
415 CAPITAL Closes New Medtech Venture Capital Fund
The fund will invest in medical device companies in Europe, Israel and the United States.
Business Wire
02.25.20
Cardiovascular
Global Cardiac Implant Market Expected to Exceed $83.7 Billion in Six Years
Growth is anticipated from rising regulatory approvals for cardiac implant devices, which will result in an increasing number of product developments.
Business Wire
09.23.19
LivaNova Welcomes New Board Member
Most recent addition boasts a career spanning more than 25 years in the healthcare and medical technology industry.
Business Wire
08.07.19
Cardiovascular
FDA OKs LivaNova's LifeSPARC Advanced Circulatory Support System
The versatile and compact system offers the power and simplicity to support more patients in more places.
Business Wire
07.15.19
LivaNova Settles U.S. Litigation Around 3T Heater-Cooler Device
The agreement provides for a total payment of up to $225 million to resolve the claims covered by this settlement.
Business Wire
03.29.19
Cardiovascular
LivaNova Launches International Study Evaluating Use of Autonomic Regulation Therapy
Trial is designed to evaluate the therapy's efficacy as a heart failure treatment.
Business Wire
10.22.18
LivaNova VNS Therapy System for Drug-Resistant Epilepsy Could Save $77K Per Patient Over Five Years
Analysis finds overall cost savings far exceed system-related costs.
Business Wire
10.09.18
LivaNova Launches Global Clinical Registry to Assess VNS Therapy Treatment
Registry is evalulating the treatment for drug-resistant epilepsy.
Business Wire
09.25.18
Cardiovascular
LivaNova Concludes PRELUDE Study for Transcatheter Mitral Valve Replacement System
Company now focused on INTERLUDE CE mark trial, building upon positive patient outcomes.
LivaNova PLC
09.12.18
Cutera Appoints Chief Operating Officer
New executive was president, North America, for LivaNova.
Globe Newswire
08.13.18
Retired BD Chief Operating Officer Joins LivaNova’s Board
New member has more than 40 years in the global medical technology industry.
Business Wire
07.24.18
Cardiovascular
LivaNova’s Perceval Sutureless Aortic Heart Valve Approved in Japan
The valve is specifically designed to reduce the physiological impact of aortic valve replacement.
LivaNova plc
07.20.18
Cardiovascular
|
Surgical
FDA OKs LivaNova's MEMO 4D Semi-Rigid Mitral Annuloplasty Ring
The company also confirmed the first implantation of the device at TriStar Centennial Medical Center in Nashville, Tenn.
Business Wire
06.14.18
LivaNova Receives CE Mark for VNS Therapy SenTiva Generator
Company also granted European approval for next-generation programming system for epilepsy treatment.
Business Wire
05.18.18
Medtech M&A Off to a Strong Start in 2018
...
Mark Bonifacio, President, Bonifacio Consulting Services
05.03.18
LivaNova Clinical Study to Evaluate Treatment Outcomes for Microburst VNS Therapy System
First patient enrolled at Rush University Medical Center in Illinois.
Business Wire
05.02.18
Acessa Health Expands Leadership Team with Key Executive Hires
Company gains three experts in medical device and healthcare business operations.
Business Wire
04.30.18
Cardiovascular
LivaNova to Divest Cardiac Rhythm Management Business to Microport Scientific
The transaction is expected to close in the second quarter of 2018.
Business Wire
03.08.18
Cardiovascular
LivaNova Announces CE Mark for PureFlex Arterial Cannulae Line for Conventional Cardiac Surgery
Company celebrates new design that delivers improved flexibility, clarity and control.
Business Wire
02.26.18
Cardiovascular
LivaNova to Acquire TandemLife for $250M
Company will add advanced cardiopulmonary temporary support solutions to its portfolio.
Business Wire
02.15.18
LivaNova Awards ECA with 2017 Supplier of the Year
Cited for providing quality and sustained value delivering precision single-procedure torque-limiting instruments.
ECA Medical Instruments
12.20.17
Neurological
LivaNova to Acquire ImThera Medical
Company will enter obstructive sleep apnea space, enhancing its portfolio of Neuromodulation treatments and therapies.
Business Wire
12.05.17
LivaNova Receives FDA Approvals for SenTiva Device, Next-Generation VNS Therapy Programming System
Products designed for epilepsy treatment.
Business Wire
10.30.17
LivaNova and MicroPort Receive CFDA Approval of Rega Pacemakers
Marks first Chinese approval for the pacemakers manufactured by the companies’ joint venture.
Business Wire
10.16.17
Neurological
LivaNova's Latest VNS Therapy System for Epilepsy Wins FDA Nod
Vagus Nerve Stimulation (VNS) Therapy offers patients with drug-resistant epilepsy a physician-directed customizable therapy.
Videos
Business Wire
Breaking News
ConKay Medical Systems Raises $1.8 Million in Seed Funding
Owlet's Dream Sock OTC Infant Pulse Oximeter OK'ed in Europe
HeartBeam Begins Study of its AIMIGo System
Baxter Reports Q1 Results; Raises Full-Year Guidance
Brent Lang Named to Outset Medical's Board of Directors
View Breaking News >
CURRENT ISSUE
May 2024
Partner Preference in Full-Service Medical Device Outsourcing
Spot Check: A Discussion of the In-Vitro Diagnostics Market
Innovative Iteration for Medical Device Design
View More >